D.A. Davidson & Co’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $751K | Sell |
|
|||||
|
2025
Q2 | $695K | Sell |
|
|||||
|
2025
Q1 | $788K | Sell |
|
|||||
|
2024
Q4 | $696K | Buy |
|
|||||
|
2024
Q3 | $733K | Sell |
|
|||||
|
2024
Q2 | $758K | Buy |
|
|||||
|
2024
Q1 | $721K | Buy |
|
|||||
|
2023
Q4 | $576K | Sell |
|
|||||
|
2023
Q3 | $519K | Sell |
|
|||||
|
2023
Q2 | $535K | Sell |
|
|||||
|
2023
Q1 | $464K | Sell |
|
|||||
|
2022
Q4 | $766K | Sell |
|
|||||
|
2022
Q3 | $481K | Sell |
|
|||||
|
2022
Q2 | $581K | Buy |
|
|||||
|
2022
Q1 | $621K | Buy |
|
|||||
|
2021
Q4 | $542K | Sell |
|
|||||
|
2021
Q3 | $538K | Buy |
|
|||||
|
2021
Q2 | $630K | Buy |
|
|||||
|
2021
Q1 | $508K | Buy |
|
|||||
|
2020
Q4 | $587K | Buy |
|
|||||
|
2020
Q3 | $499K | Buy |
|
|||||
|
2020
Q2 | $320K | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $367K | Buy |
|